# Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

> **NCT06357234** · PHASE2 · RECRUITING · sponsor: **IWK Health Centre** · enrollment: 100 (estimated)

## Conditions studied

- Spinal Fusion
- Nausea and Vomiting, Postoperative
- Anesthesia

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06357234
- **Lead sponsor:** IWK Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2027-03
- **Final completion:** 2027-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06357234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06357234, "Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06357234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*